Sofia, Bulgaria, December 19, 2024 - Pursuant to the requirements of Article 100t of the LPOS and in conjunction with Article 114, par. 9 of the LPOS, "Sopharma" AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) hereby informs, that The Board of Directors, at its meeting held on December 19, 2024, in accordance with the requirements of art. 114, para 2 of the LPOS and in accordance with the Group's strategy for optimization and focus on health related activities, approved the conclusion of the following transaction:

Sofia, Bulgaria December 19, 2024 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for November 2024 the Company recorded a decrease in sales of 10% compared to the same month of the previous year, incl. remain the same in domestic sales and 17% decrease in export sales.

For the period from the beginning of 2024, the Company recorded a decrease in sales of 8%, incl. 4% increase of domestic sales and 14% decrease in export sales.